{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:36:39Z","timestamp":1792154199637,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ejogrb.2024.11.015","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T13:28:04Z","timestamp":1731504484000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis\u2011associated chronic pelvic pain"],"prefix":"10.1016","volume":"304","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1387-0932","authenticated-orcid":false,"given":"Salvatore","family":"Caruso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cianci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Iraci Sareri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando Antonio","family":"Gulino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.11.015_b0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1933719108330568","article-title":"Priorities for endometriosis research: recommendations from an international consensus workshop","volume":"16","author":"Rogers","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0010","article-title":"Nonsteroidal anti-inflammatory drugs for dysmenorrhea","volume":"30","author":"Marjoribanks","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/GRF.0000000000000299","article-title":"Management of chronic pelvic pain","volume":"60","author":"Bishop","year":"2017","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153822","article-title":"Progesterone and estrogen signaling in the endometrium: what goes wrong in endometriosis?","author":"Marquardt","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0025","first-page":"4474","article-title":"Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol","volume":"83","author":"Zeitoun","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2016.07.497","article-title":"Mechanisms of pain in endometriosis","volume":"209","author":"Morotti","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00042192-200011000-00003","article-title":"The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms","volume":"7","author":"Speroff","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0940-2993(98)80034-1","article-title":"Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives","volume":"50","author":"Hoffmann","year":"1998","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0045","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2165\/11202820-000000000-00000","article-title":"Estradiol valerate\/dienogest in oral contraception","volume":"69","author":"Hoy","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0050","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/humrep\/der058","article-title":"Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17beta-estradiol (NOMAC\/E2): a double-blind, randomized study","volume":"26","author":"Christin-Maitre","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0055","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2022.09.007","article-title":"Estetrol is not a SERM but a NEST and has a specific safety profile on coagulation","volume":"232","author":"Douxfils","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/13625187.2022.2093850","article-title":"A novel estetrol-containing combined oral contraceptive: European expert panel review","volume":"27","author":"Gemzell-Danielsson","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humrep\/det457","article-title":"European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0075","series-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0080","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1067\/mem.2001.118863","article-title":"Prospective validation of clinically important changes in pain severity measured on a visual analog scale","volume":"38","author":"Gallagher","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0085","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/humupd\/dmz005","article-title":"Endometriosis and nuclear receptors","volume":"25","author":"Bulun","year":"2019","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0090","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3390\/biom12111654","article-title":"Emerging drug targets for endometriosis","volume":"12","author":"Dolmans","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2023.110310","article-title":"Comparison of estrogenic components used for hormonal contraception","volume":"130","author":"Stanczyk","year":"2024","journal-title":"Contraception"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5653\/cerm.2023.06128","article-title":"Dienogest in endometriosis treatment: a narrative literature review","volume":"50","author":"Lee","year":"2023","journal-title":"Clin Exp Reprod Med"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0105","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1177\/0091270011423664","article-title":"Ovulation-inhibiting effects of dienogest in a randomized, dose-controlled pharmacodynamic trial of healthy women","volume":"52","author":"Klipping","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0110","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/09513590.2018.1433160","article-title":"Heterogeneity of estrogen receptor \u03b1 and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments","volume":"34","author":"Brichant","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/JOE-15-0052","article-title":"Dienogest reduces HSD17\u03b21 expression and activity in endometriosis","volume":"225","author":"Mori","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2165\/11532130-000000000-00000","article-title":"Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy","volume":"70","author":"Lello","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0125","doi-asserted-by":"crossref","unstructured":"Caruso S, Cianci A, Iraci Sareri M, Panella M, Caruso G, Cianci S. Randomized study on the effectiveness of nomegestrol acetate plus 17beta-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis-associated chronic pelvic pain. BMC Womens Health 2022;22:146.","DOI":"10.1186\/s12905-022-01737-7"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0130","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1089\/jwh.2020.8291","article-title":"Does nomegestrol acetate plus 17\u03b2-estradiol oral contraceptive improve endometriosis-associated chronic pelvic pain in women?","volume":"29","author":"Caruso","year":"2020","journal-title":"J Women\u2019s Health (Larchmt)"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bpobgyn.2018.01.015","article-title":"Medical treatment of endometriosis-related pain","volume":"51","author":"Vercellini","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0140","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.fertnstert.2018.03.038","article-title":"Are combined hormonal contraceptives the neglected treatment for symptomatic endometriosis?","volume":"110","author":"Vercellini","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0145","article-title":"Oral contraceptives for pain associated with endometriosis","volume":"5","author":"Brown","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0150","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004695.pub2","article-title":"Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception","volume":"3","author":"Edelman","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/13625187.2018.1550576","article-title":"Hormonal contraception in women with endometriosis: a systematic review","volume":"24","author":"Grandi","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/1933719114556488","article-title":"Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate\/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study","volume":"22","author":"Grandi","year":"2015","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0165","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1080\/09513590.2021.1903420","article-title":"Estradiol\/nomegestrol acetate as a first-line and rescue therapy for the treatment of ovarian and deep infiltrating endometriosis","volume":"37","author":"Mariani","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/09513590.2015.1063118","article-title":"Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea","volume":"31","author":"Grandi","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1080\/01443615.2017.1410533","article-title":"A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea","volume":"38","author":"Uysal","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fgwh.2021.729601","article-title":"Medical treatment for endometriosis: tolerability, quality of life and adherence","volume":"2","author":"Barbara","year":"2021","journal-title":"Front Glob Womens Health"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0185","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2147\/JPR.S207599","article-title":"Effects of long-term treatment with dienogest on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain","volume":"12","author":"Caruso","year":"2019","journal-title":"J Pain Res"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/09513590.2021.1878134","article-title":"Is primary dysmenorrhea a precursor of future endometriosis development?","volume":"37","author":"Clemenza","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0195","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/humrep\/dead262","article-title":"Towards comprehensive management of symptomatic endometriosis: beyond the dichotomy of medical versus surgical treatment","volume":"39","author":"Mijatovic","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2024.11.015_b0200","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2017.01.003","article-title":"Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills","volume":"107","author":"Casper","year":"2017","journal-title":"Fertil Steril"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524006213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211524006213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T03:56:31Z","timestamp":1733802991000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211524006213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":40,"alternative-id":["S0301211524006213"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.11.015","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis\u2011associated chronic pelvic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}